Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:34 PM
Ignite Modification Date:
2025-12-24 @ 2:34 PM
NCT ID:
NCT03123159
Eligibility Criteria:
Inclusion Criteria:
* Subject is 18 years of age or older
* Subject has serological evidence of chronic HBV infection, and measurable HBV-DNA and ALT at baseline
* Subject will undergo treatment with tenofovir or entecavir for a minimum of 48 weeks
Exclusion Criteria:
* Co-infection with HIV or HCV at enrollment
* Subject has decompensated liver disease or liver cancer
* Prior participation in study
* Current or planned participation in an investigational drug or device study
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03123159
Study Brief:
Protocol Section:
NCT03123159